Cellular Microvesicle Pathways Can Be Targeted to Transfer Genetic Information between Non-Immune Cells by Skinner, Amy M. et al.
Cellular Microvesicle Pathways Can Be Targeted to
Transfer Genetic Information between Non-Immune Cells
Amy M. Skinner
1,2, S. Lee O’Neill
1,2, Peter Kurre
1,2,3*
1Pape ´ Family Pediatric Research Institute, Oregon Health & Science University, Portland, Oregon, United States of America, 2Departments of Pediatrics, Oregon Health &
Science University, Portland, Oregon, United States of America, 3Cell & Developmental Biology, Oregon Health & Science University, Portland, Oregon, United States of
America
Abstract
Eukaryotic cell communication is based on protein signaling cascades that require direct cell-cell apposition, or receptor
engagement by secreted molecules. The transmission of genetic information is thought to be uncommon, apart from recent
reports of exosomal RNA transfer in immune and glioblastoma cells. We wished to examine if existing microvesicle
pathways could be directly targeted for the horizontal transfer of RNA genomes in less specialized cell types. Using
replication-deficient retrovirus vector, studies herein confirm that a range of cells routinely sequester a small population of
these RNA genomes in a non-canonical compartment, refractory to antibody neutralization and unaffected by specific
pharmacological inhibition of pathways involved in conventional viral trafficking. Our experiments further reveal the
cytoplasmic colocalization of vector genomes with tetraspanin proteins as well as the PI-3-kinase sensitive trafficking and
subsequent transmission to 2u targets. Collectively, our results indicate a scalable process whereby cells route vector
genomes to multivesicular bodies (MVB) for cytoplasmic trafficking and exosomal release. Our findings imply that cells can
serve to deliver recombinant payload, targeted for the stable genetic modification of 2u target cells.
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Introduction
Eukaryotic cell communication is based on protein signaling via
direct cell-cell contacts, or indirectly via ligand-receptor interac-
tions. Recent work suggests that cell-cell communication may
occur in part through transfer in membrane-derived vesicles that
stem from the fusion of multivesicular bodies (MVB) with the
plasma membrane [1]. Unlike the exchange of DNA episomes
seen in prokaryotes, the cell membrane and cytoplasmic
environment in higher order species present a substantial barrier
for the trafficking of nucleic acids. The recently described
microvesicle transfer of RNA between glioblastoma cells or the
exosomal cell-cell transmission of microRNA in mast cells provide
highly specialized exceptions of ‘‘horizontal’’ genetic communica-
tion among target cells [2,3]. Fundamentally, those studies
demonstrate microvesicle mediated transfer and cytoplasmic
detection of donor cell ‘‘RNA signatures’’ in 2u targets. Little is
known about the recruitment and trafficking of RNA to such a
pathway and its potential existence in less specialized cell
populations. Specifically, there have been no demonstrations of
long-lived effects in 2u targets, nor attempts to directly exploit such
genetic communication.
During recent studies investigating the cell-cell transfer of
replication incompetent VSV-G pseudotyped particles, we ob-
served a population of intracellularly captured particles refractory
to neutralization by envelope-specific antibody or protease, and
capable of 2u transfer [4,5]. Based on these intriguing observa-
tions, we hypothesized that replication deficient RNA vector
genomes might be subject to recruitment into a microvesicle
transfer pathway. In sharp distinction to prior studies that rely on
endogenous protein and RNA cargo, tagged retrovirus vectors
allow us for the first time to prospectively follow genome
trafficking in the donor (1u target) cell. Late generation HIV-1
derived lentiviral vector particles use split packaging designs and
their RNA transfer genome is devoid of open reading frames
required for viral replication, collectively intended to prevent
mobilization, packaging and spread of the vector genome. Viral
replication incompetence truncates the vector life cycle, and
conceptually, replication-incompetent retrovirus is thought to
follow one of two fates upon cell entry: nuclear translocation
and integration at its genomic destination, or rapid cytoplasmic
degradation in lysosomes or proteasomes [6,7]. Replication
deficiency therefore avoids bias from viral assembly and trafficking
during egress, and provides a sensitive experimental system with
readily traceable, stable biologic effects in the 2u target.
We now demonstrate that cells sequester genomes in a non-
canonical microvesicle compartment enriched in tetraspanin
proteins where they bypass routing to the nucleus, escape a
degradative fate and transfer to a 2u target. Cytoplasmic trafficking
is susceptible to inhibition of phosphatitdyl inositol-3-kinase (PI-3-
K) activity and can be exploited for the deliberate and scalable
cellular delivery of integrating genetic sequence.
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Cells retain recombinant vector genomes in a protease-
resistant intracellular compartment
We and others previously described the saline wash-resistant
persistence of lentivector particles and their conditional transfer to
2u cells [5,8]. To distinguish prolonged cell surface adherence
from intracellular capture, SupT1 cells were exposed to VSV-G
pseudotyped GFP-encoding lentivector at 37uC, or 4uC to allow
binding while preventing uptake [9,10], followed by serial washes
in PBS and direct co-culture on pre-plated 293T fibroblasts, as
indicator cells. GFP expression in (CD45 negative) 293T cells as
an indication of genome transfer, integration and expression was
seen in both conditions (Fig. 1A). By contrast, vector exposure at
4uC, followed by pronase treatment degraded surface bound
particles without significant marking in 293T cells. Remarkably,
when vector exposure at 37uC was followed by pronase treatment
(at concentrations experimentally determined to degrade surface-
bound particles, Fig. S1A) we reliably observed GFP expression in
a low (0.1–1%), but consistent percentage of co-cultured 293T
cells, progressively increasing in magnitude during extended vector
exposure duration in 1u cells (Fig. 1A, open red squares). This is
confirmed by real-time PCR studies that show the amplification of
proviral GFP sequences in DNA extracted from 293T 2u targets
escalating in concert with input MOI during 1u cell exposure (Fig.
S1B). Secondary transfer was scalable across a wide range of
conditions, and we consistently observed the 1u cell exposure time-
and dose-dependent correlation of genome transfer and stable
proviral expression in 2u cells (here K562 cells, Fig. 1B,C). Results
were confirmed in lymphoid (Raji) cells; HepG2 human hepatoma
cells and for alternate (ecotropic) pseudotype and c-retroviral
transfer vectors (Fig. S1C,D). Gain in replication competence
(p24Gag ELISA) in vector lots, as well as experimental
supernatants in these and subsequent experiments, was specifically
excluded. Together, these data reveal that cells retain a fraction of
vector genomes in a protease-resistant compartment for transfer to
2u targets.
Prolonged sequestration and delayed transmission
We next evaluated the rate of genome cell-cell transfer. Murine
L1210 cells were exposed to VSV-G GFP vector particles, washed
in pronase and independently propagated for up to five days,
before transfer to co-culture with 293T cells. Results indicate the
transmission of genomes as late as five days after the initial
exposure, with a peak at 24 hours, followed by subsequent decline
(Fig. 1D). Flow-cytometric detection of GFP expression in 293T
cells 16 days after co-culture (293T doubling time: 18 hours, data
not shown) exclude simple GFP protein transfer (Fig. S1E). In
repeat experiments we collected 1u cell aliquots at serial time
points, from 0 to 76 hours after vector exposure for real-time RT-
PCR to detect cytoplasmic vector-RNA genome-specific long
terminal repeats (LTR). Results confirm that LTR- genomes
decline by about 8–10 fold, but remain detectable at all time points
examined, at levels specifically determined to exceed residual
transcriptional background activity from SIN modified vectors
(Fig. 1E) [11,12]. The resulting curves track the reverse
transcription and predicted decay of RNA genomes, as well as
the appearance of persisting integrated (DNA) provirus. Additional
independent validation comes from the extended detection of
p24(Gag) protein by immunoblot and densiometric analysis at
serial time points following vector exposure (Fig. 1F). Finally, we
used GFP-vpr fusion protein tagged particles and undertook
deconvolution immunofluorescent microscopy [13,14]. HIV-1
derived Vpr binds to the viral capsid (Gag), allowing for
cytoplasmic tracking of GFP-vpr tagged particles. Thus, the
observed p24 colocalization with GFP-vpr provides further
support for the prolonged presence of particle cores at time points
up to four days after vector exposure (Fig. 1G–I). Together,
multiple lines of evidence lead us to conclude that cells routinely
sequester genomes in the cytoplasm where they escape degrada-
tion and nuclear translocation.
Vector cores undergo minimal processing
During the vector life cycle the particle is taken up into the cell,
where the core is rapidly uncoated to undergo reverse transcrip-
tion and generate the pre-integration complex [7]. To test whether
reverse transcription itself was limiting to 2( transfer, we pre-
incubated 293T cells for 8 hours with increasing concentrations of
reverse transcription inhibitor azidothymidine (AZT), followed by
a 3-hour vector exposure (+AZT), pronase wash, and direct co-
culture with Jurkat cells (- AZT). The almost undiminished levels
of genome transfer and GFP expression in 2( cells indicate that
reverse transcription is not a requirement for cell-cell transfer
(Fig. 2A). To further investigate the extent of genome processing in
1o cells we exposed Jurkat cells to VSV-G pseudotyped vector,
followed by pronase wash and direct co-culture with 293T cells,
and observed that 2( transfer was almost completely abrogated in
the presence of a neutralizing anti-VSV-G antibody, but not IgG
isotype (Fig. 2B). This suggests that the vector retains its envelope
during cell-cell transfer and that genome processing during
cytoplasmic trafficking and transfer from 1( to 2( cell is minimal.
Confirming these results, we found no 2( transfer after exposure of
murine L1210 cells to ecotropic pseudotyped lentivector and co-
culture with (non-permissive) human 293T cells (not shown),
indicating that cytoplasmic passage does not appear to alter the
tropism for 2( transfer. The detection of VSV-G protein by
immunoblot (Fig. 2C) and immunofluorescent deconvolution
microscopy (Fig. 2D–F) collected at serial time points following
vector exposure further support the sequestration of unprocessed
genomes. Concurrent localization of GFP-vpr (gag) with VSV-G
envelope provides additional validation for the presence of intact
particles (Fig. 2D–F). The observed lack of processing following
sequestration is consistent with a general cellular pathway rather
than conventional vector trafficking.
Pharmacological modulation of conventional trafficking
pathways and 2u transmission
Given the pH dependent uptake of VSV-G pseudotyped
particles, we next explored the role of endosomal routing by
treating SupT1 carrier cells with ammonium chloride, a selective
inhibitor of vacuolar H+ ATPases [15]. Treatment was initiated
prior to vector exposure and maintained during subsequent co-
culture with 293T cells. While we found the anticipated decrease
in uptake of particles in carrier cells [15], we noted largely
unchanged rates of 2u transfer, in turn resulting in up to a 20-fold
proportional increase in the efficiency of 2u transfer to 293T cells
(Fig. 3A). These results were confirmed after pH modulation with
chloroquine and point to a method for manipulating the
trafficking [13] (Fig. 3B). By contrast, when we inhibited
proteasome degradation, lysosome transportation, or actin poly-
merization, we did not observe significant effects on 2u transfer
(Fig. S2A–C). The endosome is a principal cellular compartment
involved in protein signaling [14], and we performed deconvolu-
tion microscopy to determine if it was similarly implicated in
trafficking vector genomes. We evaluated the intracellular location
of GFP-vpr tagged vector genomes and their colocalization with
select endosomal compartments: AP2 (clathrin adaptor protein),
EEA1 (early endosomes), H68.4 (transferrin receptor: early and
Cell-Cell Transfer of RNA
PLoS ONE | www.plosone.org 2 July 2009 | Volume 4 | Issue 7 | e6219Figure 1. Vector uptake into a protease-resistant compartment and subsequent transfer. (A) GFP marking in (CD45 negative) 293T 2u
cells following coculture with vector exposed SupT1 cells washed in media (shaded) or pronase wash (non-shaded). Error bars represent standard
deviation between samples. (B) K562 cells were vector-exposed, pronase-washed and co-cultured with 293T cells. CD45-APC staining captured 90%
of myeloid population, implying that %GFP positive 293T cells (C) may reflect a minor percentage of admixed residual K562 cells. (D) L1210 cells
were exposed to vector at low MOI for 3 hours, followed by pronase wash, independent propagation for designated time (x-axis), and coculture with
293T cells. Vector genomes in 293T cells were detected by FACS with exclusion of 1u cells by CD45 staining. (E) L1210 cells were exposed to vector for
increasing lengths of time (x-axis) and washed with pronase. RNA was collected, reverse transcribed with random hexamer primers, and quantitative
real-time PCR was performed using primers to detect proviral GFP sequence (DNA) or dLTR sequence (vector genome RNA). (F) Densiometric analysis
and p24 immunoblot (inset). Cell lysates prepared from vector-exposed, pronase-washed Jurkat cells, resolved on a 10% PAGE gel, probed with
antibody against p24 or b-tubulin. (G) GFP-vpr labeled genomes (green), anti-p24 was fluorescently labeled AlexaFluor 647 (far-red), and colocalized
GFP-vpr with p24 particles (yellow) were counted in each cell. The y-axis represents the percent of total cells counted with a given number of
colocalized particles. (H, I) Representative images of Jurkat cells on day 1 and 4, respectively, after vector exposure.
doi:10.1371/journal.pone.0006219.g001
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sis/exocytosis [16,17]). Cells were stained with anti-Golgin 97
antibody (Golgi) as a negative control, or an anti-lysosomal
antibody (LAMP1) as a positive control for degradation in the
lysosome. In both Jurkat and SupT1 cells, up to 10% of genomes
were found to colocalize with individual endosomal markers
following a 1-hour vector exposure (Fig. 3C,E, Fig. S2C). A similar
percentage of particles was found to colocalize with endosomal
compartments following a 24-hour vector exposure (Fig. 3D,F,
Fig. S2C). Approximately 10% of particles also colocalized with
the endosomal/exosomal marker N-Rh-PE in Jurkat cells, at both
early and late time points (Fig. 3C,D). Overall, similarly low
frequencies of co-localization with Golgi, LAMP1, and endosomal
markers illustrate ongoing canonical endosomal trafficking,
processing by Golgi, and degradation by the lysosome between
the time points examined. We conclude that sequestration and
trafficking predominantly occur in a cytoplasmic compartment not
identified by conventional endosomal markers.
Tetraspanin-enriched compartments traffic vector
particles in 1u target cells
Tetraspanin proteins associate with endocytic and plasma
membranes [18] and organize a number of signaling complexes
[19]. To investigate whether sequestration and transmission occur
from a tetraspanin-enriched compartment, we serially imaged cells
exposed to GFP-vpr tagged vector genomes by deconvolution
immunofluorescent microscopy. Results not only demonstrate a
cellular distribution of both tetraspanins, CD63 and CD81
consistent with the literature [20,21], but reveal substantial
colocalization of GFP tagged genomes and kinetics that parallel
those of 2u transfer observed in co-culture studies (Fig. 1D).
Minimal co-localization with CD81 at 1-hour vector exposure is
followed by robust (p=0.002, MANOVA test) gains at 24-hour
after vector exposure and a subsequent decline at 48 hours
(Fig. 4A,C). By contrast, colocalization of GFP-vpr with CD63
showed relatively little variation over time (Fig. 4B,C).
Tetraspanin proteins are constitutive components of exosomes,
which derive from structures termed multivesicular bodies (MVB)
that are involved in cellular trafficking [22]. Reflecting the
potential involvement of this organelle in sorting material to
exosomes [23] we investigated its role in trafficking genomes.
These imaging studies revealed colocalization of GFP-vpr labeled
genomes and tetraspanins with MHC class II protein, and the
exocytosis marker N-Rh-PE [24], supporting the role of MVB in
sequestration and cell-cell transfer (Fig. 5A,B). Looking to provide
additional support for the transfer of genomes among 1u (SupT-1)
and 2u target cells (293T, distinguished by their DsRed labeled
Figure 2. Vector particles persist in an unprocessed state. (A) 293T 1u cells were incubated overnight in AZT, followed by 3-hour vector
exposure in the presence of AZT, pronase wash, and co-culture (without AZT) with Jurkat 2u cells. GFP expression was determined in the 2u CD45+
(Jurkat) population by FACS. (B) Jurkat cells were exposed to vector, pronase washed, and placed in co-culture with 293T cells with (+/2) anti-VSV-G
neutralizing antibody. GFP was examined by FACS. (C) VSV-G immunoblot of cell lysates prepared from from vector-exposed, pronase-washed Jurkat
cells probed with antibody against VSV-G or b-tubulin. The positive control is neat vector; each lane corresponds to the day of (or after) vector
exposure. (inset) Densiometric analysis of immunoblot (D) Jurkat cells were exposed to GFP-vpr tagged vector, washed with pronase, and
propagated in culture for 4 additional days. The vector genomes are GFP-vpr labeled (green), and anti-VSV-G is fluorescently labeled with the 2u
antibody AlexaFluor 647 (far-red). Colocalized GFP-vpr and p24 particles (yellow) were counted in each cell. The left y-axis represents the percent of
total cells counted with a given number of colocalized particles. The right y-axis represents the percentage of particles associated with VSV-G
envelope. (E, F) Representative images of Jurkat cell on day 1 and 4, respectively, after vector exposure. GFP-vpr particles (green), anti-VSV-G
antiserum (magenta), and colocalized particles (white) are shown.
doi:10.1371/journal.pone.0006219.g002
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copy to directly track genomes trafficked in MVBs (i.e. CD81
associated). We labeled 1u cells with anti-CD81 (magenta) and
tracked GFP-vpr tagged genomes (green) during transfer. Early on
during imaging, CD81 colocalized particles (magenta/green
overlay=white, arrow) cluster at the limiting membrane. Success-
fully transferred genomes then colocalize with DsRed actin
(magenta/green/red overlay=yellow, box) inside the 2u cells
(Fig. 5C).
MVB formation can be experimentally disrupted by specific
inhibition of phosphatidyl inositol 3-kinase (PI3-K) with LY-
294002 [24]. We wished to directly visualize the effect MVB
Figure 3. Endosomal acidification increases the proportional efficiency of secondary transfer. (A) Effect of endosomal acidification on 2u
transfer. SupT1 carrier cells were pretreated with escalating doses of ammonium chloride or chloroquine (B) followed by vector exposure, pronase
wash, and 24-hour coculture with 293T cells. Primary transduction (gray), secondary transfer (black), and proportional % efficiency of secondary
transfer (red) are shown. (C,D) Colocalization of vector genomes with representative endosomal markers. Jurkat cells and (E,F) SupT1 cells were
exposed to GFP-vpr tagged vector for 1 (C,E) or 24 hours (D,E). Cells were stained with antibodies against indicated endosomal cellular
compartments (x-axis), as well as Golgin 97 (negative control) and LAMP1 (positive control), and cells were visualized by immunofluorescent
microscopy for determination of co-localization of particles and specific compartment markers. The total number of particles (gray, numerator in each
column) and total number of co-localized particles (black, denominator in each column) were counted.
doi:10.1371/journal.pone.0006219.g003
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PLoS ONE | www.plosone.org 5 July 2009 | Volume 4 | Issue 7 | e6219Figure 4. Vector particles are associated with tetraspanin-enriched compartments. Jurkat and SupT1 cells were exposed to vector for 1 or
24 hours. Cells were stained with Hoechst 33342 nuclear stain, washed, fixed, permeabilized, cytospun, and stained with anti-CD81 or anti-CD63
antibody (TAPA1, tetraspanin). (A,B) Vector genome association with select tetraspanins. Columns represent total vector number (gray, numerator in
each column) over particles colocalized with tetraspanins (black, denominator in each column). Fluorescent images were deconvolved to confirm
intracellular particle location. (C) Representative images illustrating vector genome association with tetraspanins. Particles are GFP-vpr labeled
(green), CD81 or CD63 tetraspanin is 2u-labeled with Alexa Fluor 647 (far-red). Yellow indicates colocalization of the two fluorescent signals. Only fully
merged and overlapping particles were counted as colocalized.
doi:10.1371/journal.pone.0006219.g004
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and concurrently exposed cells to LY-294002, the exocytosis
marker N-Rh-PE, and GFP-vpr vector, followed by pronase wash
and stain with anti-CD63. While colocalization with CD63
remained relatively unaffected, association with N-Rh-PE de-
creased with time, in contrast to the non-treated control (Fig. 6A,
B). To confirm the functional relevance of MVB involvement, we
repeated this experimental set-up in a co-culture assay and
observed a LY-294002 dose-dependent decrease in 2u transfer
(Fig. 6C). Along with co-culture transduction studies, these
observations indicate that blocking MVB formation results in
altered cytoplasmic trafficking and subsequent decrease in 2u
transfer of genomes. In sum, these experiments implicate MVB in
sequestration and 2u transfer of RNA-genomes.
Discussion
The physiologic transfer of information between eukaryotic cells
relies on protein-based signaling cascades. More recent studies
have reported the horizontal, non-infectious, transfer of genetic
sequence (RNA) by MVB-derived exosomes and microvesicles
between highly specialized cells [2,3,4,25,26]. Those reports lend
general support to a model of horizontal RNA transfer and genetic
cell-cell communication, but focus on the ‘‘passive’’ detection of
Figure 5. Vector particles associate with MVB markers. (A,B) Vector genomes associate with select MVB markers. Jurkat cells exposed to GFP-
vpr vector (green) overnight, followed by pronase wash, and stain with antibodies against CD81, CD63, or N-Rh-PE (red), MHCII (magenta). Particles
found associated with CD81 and MHCII, or N-Rh-PE and MHCII are white. (C) Live cell imaging of vector-exposed, pronase-washed 1u SupT1 cells
(labeled with anti-CD81, Alexa Fluor 647, magenta) in co-culture with 2u 293T DsRed actin (red) expressing cells. Right hand panels lack the DsRed
layer for improved visual clarity of otherwise identical frames. Genomes co-localized with tetraspanin are white (arrows, boxes). Genomes co-localized
with DsRed actin are yellow. Deconvolution microscopy was performed on live cells by collecting series of z-stacks (0.5 mm) every minute for 10
minutes, elapsed time is indicated in black.
doi:10.1371/journal.pone.0006219.g005
Figure 6. Inhibiting MVB formation abrogates 2u transfer. (A) Enumeration of GFP-vpr vector genomes (green) associated with select MVB
markers (N-Rh-PE, red and CD63 tetraspanin, magenta) following exposure to 100 mM LY-294002. Cell aliquots were collected at 1 and 3 hours
following exposure. (B) Top panels are representative images from untreated cells, bottom panels representative of treated cells. (C) Functional
effect of LY-294002 on 2u transfer of vector genomes. Jurkat carrier cells were pretreated with escalating doses of LY-294002 as in (A,B) followed by
vector exposure for 3 hours in the presence of the inhibitor, pronase wash, and 24 hour co-culture with 293T cells. Primary marking (gray), 2u transfer
(black), and % efficiency of 2u transfer (red) are shown.
doi:10.1371/journal.pone.0006219.g006
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ized cells with the demonstration of rare and transient donor cell
derived biologic effects in 2u target cells [27,28]. To better
understand the nature and therapeutic potential of such a process,
we chose an alternate approach that allowed us to shift the
experimental focus to trafficking in 1u cells, and the demonstration
of heritable effects in 2u target cells.
We previously reported the cell-cell transfer of VSV-G
pseudotyped, replication-incompetent HIV-1 derived vector from
hematopoietic cells to 2u targets [5]. Systematic dissection of this
observation using transduction rescue assays, PCR analyses for
vector genomes, western blotting and deconvolution microscopy,
studies herein provide compelling evidence that a wide range of
cell types are capable of successfully transmitting vector genomes
in a process that is scalable (dose-dependent) at the level of vector
input. Sequestered, GFP-vpr tagged genomes were found to
localize at the cell membrane of the 1u cell up to four days after
exposure (last time point tested). Indeed, the delayed visualization
of GFP-vpr labeled (i.e. Gag associated) genomes in 1u and 2u
target cells by deconvolution microscopy indicates that this does
not simply represent horizontal transfer of circular LTR-DNA
species, for which nuclear processing and loss of Gag are
prerequisites [29]. Moreover, the delayed detection of provirus
by quantitative real-time PCR analysis in rapidly dividing 2u
targets demonstrates stable integration and excludes the mere
transfer of protein products [29,30]. In fact, undiminished cell-cell
transfer after RT inhibition in 1u vector-exposed cells implies that
genomes do not complete core processing, nor is there a
requirement for integration into the primary target.
Because endosomes are involved in protein-mediated cell
signaling [14], and VSV-G pseudotyped particles enter the cell
through endocytosis, we initially tested involvement of the
endosomal compartment, but found only low-level constitutive
colocalization with endosomal markers (EEA1, transferrin recep-
tor, clathrin adaptor AP-2) by immunofluoresecent microscopy.
On the other hand, we observed significant intracellular
colocalization of GFP tagged genomes with tetraspanins, CD63
and CD81, that peaks at 24-hours, in kinetics reflecting our
functional studies. In distinct contrast to viral trafficking [22], 2u
transfer capacity was unaffected by experimental disruption of
canonical processing involving proteasomal and lysosomal func-
tion, or depolymerization of the actin cytoskeleton [4,25,31,32].
Intriguingly, these attributes are consistent with microvesicle
involvement, whereby multivesicular bodies (MVB) evolve from
late endosomes to overcome the subcortical actin barrier, and fuse
with the plasma membrane to release their exosome content
[33,34,35]. In keeping with this hypothesis, we observed significant
colocalization of genomes with proteins enriched in MVB,
including the exocytosis marker (N-Rh-PE) and, albeit to a lesser
extent, MHC II [20,28] in kinetics again corresponding with
functional assays of 2u transfer. Indeed, specific inhibition of MVB
formation with LY-294002 resulted in time-dependent loss of
genome colocalization with N-Rh-PE in imaging experiments as
well as dose-dependent diminution of 2u transfer in co-culture
experiments. Collectively, these experiments support the involve-
ment of MVB structures in particle retention (kathexis), and the
directed transfer of genetic material between cells. Unlike existing
studies [22,27,36], these results imply a horizontal RNA transfer
pathway between cells that is accessible to integration competent
genomes, and therefore directly amenable to manipulation, Fig. 7.
Two alternate, not mutually exclusive, hypotheses may explain
what directs genomes to this pathway. Work by Skog and
colleagues suggests that specific RNA sequence tags may be
responsible for directing genomes into an exosomal pathway [2].
This possibility is consistent with the detection of endogenous
retroviral RNA species in exosomal preparations [37]. Alterna-
tively, gag itself may be responsible for sorting cores into
microvesicle export pathways [20,38]. In either case, the transfer
of genetic information allows for prompt adaptation of cell
populations to alterations in the microenvironment, and may help
explain why hypoxia, irradiation, or cell activation augment
microvesicle release [2].
While reported instances of exosomal transfer have demon-
strated endogenous cellular protein, and more recently RNA, as
microvesicular cargo [39], data presented here for the first time
suggest that such a transfer pathway can be actively targeted for
delivery of replication deficient particles. Thus, at the level of the
2u target tissue, both stable sequence over-expression as well as
RNAi based target ablation can be conceptually accommodated
and specific molecular targets can be pursued. Our findings imply
a novel therapeutic approach for the selective and scalable delivery
of genetic sequence in a desired tissue- and cell-specific manner.
Materials and Methods
Cell culture
SupT1 cells (a human T-cell line) were grown in RPMI (Gibco)
supplemented with 10% FBS (Gibco), 1% Penicillin/Streptomycin
(Pen/Strep, Gibco), 1 mM sodium pyruvate, 10 mM Hepes, and
2 mM L-glutamine. HepG2 human hepatoma cells were grown in
MEM (Gibco) supplemented with 10% FBS, 1% Pen/Strep,
1 mM sodium pyruvate, and 1 mM nonessential amino acids
(Gibco). HEK 293T human kidney fibroblasts and NIH 3T3
murine fibroblasts were grown in DMEM (Gibco) supplemented
with 10% FBS and 1% Pen/Strep. Human Jurkat T-cells, murine
lymphoid L1210 cells, and human K562 myeloid leukemia cells
were all grown in RPMI supplemented with 10% FBS and 1%
Pen/Strep.
For direct co-culture experiments, 1610
5 293T cells were
seeded in a 12-well tissue culture plate (Costar). Vector-exposed
non-adherent hematopoietic cells were washed and placed
alongside pre-plated fibroblasts for 24 hours, after which time
non-adherent cells were aspirated. Residual cells were stained with
anti-CD45 and analyzed by flow-cytometry to distinguish
hematopoietic cells from fibroblasts (below). For pronase washes,
cells were pelleted immediately following transduction and
resuspended in 1 mg/ml pronase (Roche) for 10 minutes at
37uC followed by two washes in media containing 10% FBS. Cells
were then re-suspended in corresponding culture media.
In select experiments we pretreated 1u cells with MG 132
(EMD), Bafilomycin A (PKC Pharmaceuticals), Ammonium
Chloride (Fisher), Chloroquine (Sigma), AZT (Sigma), Latrunculin
A and B (Biomol). In specified experiments these reagents were
also present during co-culture. The VSV-G neutralizing antibody
was collected from the supernatant of a hybridoma (CRL-2700,
American Type Culture Collection) and concentrated with
Amicon Ultra columns (Millipore). Anti-IgG antibody was
generously provided by Philip Streeter, OHSU Stem Cell Center.
Vector preparation and transduction
Human 293T kidney fibroblasts cells were seeded at a density of
1.6610
7 cells per 15-cm tissue culture dish (Corning), precoated
with 0.01% poly-L-lysine (Sigma). The lentivirus transfer vector
pRRL SIN EF1a cPPT EGFP wpre LoxP (pWPXL-EGFP) was
kindly provided by D. Trono (Geneva, Switzerland). The GFP-vpr
plasmid was provided by Eric Barklis (Portland, OR). The c-
retrovirus vector pMND MFG eGFP was kindly provided by
Donald Kohn. Calcium phosphate transfection of lentivector
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plasmids was performed in DMEM, 10% FBS, 1% Pen/Strep.
Vector supernatant was harvested 36, 48, and 72 hours later,
filtered through a 0.45 mm filter, ultra-concentrated over 30 hours
at 7300 RCF, and the pellet was resuspended in Iscove’s media
(Gibco) and stored at -86uC until use. Limiting dilution titers were
determined by FACS and calculated using 293T cells, as
previously described [40]. Cells were washed and resuspended in
corresponding media (described below), with 4 mg/ml protamine
sulfate (MP Biomedicals). Transductions took place at 37uCo r
4uC for specified lengths of time.
Flow-cytometry
Retroviral transduction was analyzed by GFP expression using a
FACS-Calibur instrument (BD Biosciences) using Flow Jo software
(Tree Star, Ashland, OR). For determination of cytoplasmically
located vector genomes, cells were collected and analyzed
following vector exposure; for determination of events that resulted
in nuclear integration, cells were collected and analyzed 72 hours
following vector exposure (to allow for transcription, translation,
and processing of protein). At least one hundred thousand events
were collected for any given sample. Cells of hematopoietic lineage
were determined by staining with anti-CD45 (murine, PE-
conjugated, BD Biosciences or human, APC conjugated,
eBioscience). Non-viable cells were excluded from analysis by
uptake of propidium iodide (1 mg/ml).
p24 Enzyme-linked immunosorbent assay (ELISA)
To verify replication incompetence, testing was performed by
transducing SupT1 cells with vector supernatant for 24 hours,
followed by washing, and serial passage of cells for 2 weeks in
culture. Cellular supernatant was collected for p24 (Gag) ELISA
(Perkin-Elmer, Boston, MA) and samples were run in duplicate per
manufacturer’s protocol. No samples tested positive.
Quantitative real time RT-PCR
Total RNA was extracted from cells using an RNeasy Mini Kit,
according to manufacturer’s protocol (Qiagen Inc., Valencia, CA)
and subjected to DNase treatment. Complementary DNA was
made using SuperScript
TM RT (Invitrogen). Expression was
determined via quantitative real-time PCR on a StepOne Plus
ABI sequence detection system (Applied Biosystems). The primers
used to detect proviral GFP were sense: 59 GTG GTG CCC ATC
CTG GTC GAG C -39 and anti-sense: 59- CAC CAG GGT GTC
GCC CTC GAA C -39. The primers used to detect proviral long
terminal repeats (dLTR) were sense: 59-TGT GTG CCC GTC
TGT TGT GT-39 and anti-sense: 59-GAG TCC TGC GTC
GAG AGA GC-39. Amplification using random hexamer or oligo
dT primers exhibited similar kinetics, providing internal valida-
tion. The primers used to detect the endogenous GapDH
endogenous control were sense: 59- AAA TAT GAC AAC TCA
CTC AAG ATT GTC A -39 and anti-sense: 59- CCC TTC CAC
AAT GCC AAA GT -39. Reactions were set up in a MicroAmp
Figure 7. Working model of intracellular trafficking and horizontal transfer of RNA genomes. Particles carrying RNA genomes are taken
up into a cell, processed, and traffic the cytoplasm destined for nuclear integration or degradation by the proteasome or lysosome. Alternatively,
some genomes are retained in MVB (kathexis), avoid processing, and can be released to transfer to 2u cells. Cell markers (e.g. antibodies) used in these
experiments are listed below their corresponding compartment.
doi:10.1371/journal.pone.0006219.g007
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using Power SYBR Green PCR Mastermix (Applied Biosystems),
and run in triplicate. All threshold cycle (Ct) values of GFP were
normalized to GapDH endogenous control Ct values. For
determination of plasmid copy number, dilutions of plasmid
containing dLTR and GFP were titrated and quantitative real-
time PCR was performed using each primer set. A standard linear
regression model was applied to determine the best fit between
lines to compensate for differences in amplification efficiency (for
variance between intercepts and slope p,0.001).
Deconvolution Microscopy
Deconvolution microscopy was performed at the OHSU
Department of Molecular Microbiology and Immunology Shared
Resource. The Applied Precision Deltavision Image Restoration
System
TM includes a chassis with precision nano-motorized XYZ
stage, an Olympus IX71 wide field microscope, a Nikon Coolpix
HQ Camera; and DeltaVision SoftWoRx
TMsoftware. Deconvolu-
tion is performed with SoftWoRx software (Applied Precision), and
additional image processing is performed with Bitplane Imar-
is
TMsoftware. Images were acquired using the 6061.4NA oil lens.
Z-stacks of 3 colors (Hoechst33342, GFP, and Alexa-Fluor 647)
were acquired at 0.5 mm for the complete depth of the cells
(approximately 19–20 Z-planes) and were deconvolved for 9
iterations with the appropriate (experimentally determined) point
spread function (PSF). Histograms were adjusted to display the
data as 24 bit RGB tiffs and movies. Rotational movies were made
from 3D volumes created in Imaris (ver. 5.7.2). Adobe Photoshop
was used to separate color channels.
Immunofluorescence
Jurkat and SupT1 cells were transduced with GFP expressing
vector particles (GFP-vpr) at a density of 2.5610
5 cells for
designated transduction times, followed by Hoechst 33342 staining
(5 mg/ml, Invitrogen) for 1 hour. Cells were fixed for 15 minutes
at room temperature in 4% paraformaldehyde, and permeabilized
for 10 minutes at 4uC with NET buffer (150 mM NaCl, 5 mM
EDTA, 10 mM Tris, pH 7.4, with 0.5% triton X-100), as
previously described [41]. Cells were then cytospun onto glass
slides. Cells were stained for 1 hour with 1u antibody in PBS with
2% FBS (Gibco), washed, stained for 1 hour with 2u antibody
(Alexa Fluor 647, Invitrogen) in PBS with 2% FBS, washed, and
mounted with Fluoromount G (Fisher) onto glass slides. The 1u
antibodies used were anti-CD63 (BD Biosciences), anti-CD81
(Abcam), anti-AP2 (Abcam), anti-MHCII (Abcam) and anti-
transferrin receptor (H68.4, Zymed). EEA1 and Golgin 97-specific
antibodies were generous gifts from Dr. Caroline Enns (Portland,
OR). The monoclonal antibodies against LAMP-1 and CD63
were developed by J. Thomas August and James E.K. Hildreth,
and were obtained from the Developmental Studies Hybridoma
Bank developed under the auspices of the NICHD and maintained
by The University of Iowa, Dept. of Biological Sciences, Iowa
City, IA 52242. The p24 antiserum was collected from the
supernatant of murine Hy183 hybridoma cells, generously
provided by Dr. Eric Barklis. The number of cells examined in
the experiments illustrated in each figure is given in Table S1.
To determine extended duration of genomes, Jurkat cells were
exposed to GFP-vpr tagged vector, washed with pronase, and
propagated in culture for 4 additional days. Cell aliquots were
prepared for imaging (cytospun and stained with corresponding
antibodies) serially every 24 hours.
To trace endocytic/exocytic pathways, Jurkat and SupT1 cells
were exposed to 5 mg/ml Lissamine rhodamine B (N-Rh-PE,
Avanti Polar Lipids, Alabaster, AL) for 1 hour (endocytosis) or
24 hours (exocytosis). Cells were washed in PBS and prepared, as
described, for microscopy.
To visualize the effect of PI3-K inhibition, 2.5610
5 Jurkat cells
were pretreated for 30 min with LY-294002 (EMD Bioscience),
followed by a 3-hour vector exposure in the presence of the inhibitor,
pronase wash, and preparation for imaging as described above.
For visualization of actin filaments, 293T were stably transfect-
ed with DsRed-Monomer-Actin Vector (Clontech). DsRed-
expressing cells were single-cell sorted on an Influx instrument
(Cytopeia) and cultured in 2 mg/ml G418 (Invitrogen) for
isolation and maintenance of stably integrated clonal events.
Western Blotting
Cells were exposed to VSV-G pseudotyped vector (MOI 3) for
5 hours, followed by pronase wash. At serial time points, 1.5610
6
cells were pelleted and lysed with buffer containing 0.15 M NaCl,
5 mM EDTA, 1% Triton X-100, 10 mM Tris-Cl, Halt Protease
Inhibitor Cocktail (Thermo Scientific), and 5 mM DTT. Lysates
were resolved on a 10% polyacrylamide gel, transferred to
membrane, stained with 1u antibody p24 anti-serum, VSV-G
antibody (Sigma), or antibody against b-tubulin (Santa Cruz
Biotechnologies) or GAPDH, and anti-HRP 2u antibody (Amer-
sham). Images were visualized on a Lumi-Imager (Roche Applied
Science) and densiometric analysis was performed with LumiA-
nalyst 3.1 software.
Statistics
Numerical results are expressed as average plus or minus
standard deviation (SD). Data were analyzed using the paired 2-
tailed Student t-test. P values of less than 0.05 were considered
significant. For determination of significance of co-localization in
microscopy experiments, a multivariate analysis of variance
(MANOVA) was performed. To confirm results, an F-test was
performed.
Supporting Information
Figure S1 (A) Vector was incubated in increasing concentrations of
pronase for 10 minutes, followed by vector exposure in murine L1210
cells. GFP marking was determined by FACS. (B) Vector genomes
detected in 293T cell DNA 72 hours post-coculture with vector-
exposed, pronase-washed L1210 cells by qRT-PCR with GFP-
specific primers. (C) Raji (human B) cells were exposed to increasing
numbers of vector genomes overnight, followed by pronase wash and
coculture with 293T cells. GFP marking is shown in 1o Raji (closed
circles) and 2o 293T cells (open circles). (D) Murine L1210
hematopoietic cells were exposed to increasing numbers of
c2oncoretroviral vector genomes overnight, followed by pronase
wash and coculture with 293T cells. GFP marking is shown in 1o
L1210 (closed circles) and 2o 293T cells (open circles). (E)
Representative FACS plots generated from samples of 293T 2o cells
corresponding to (Fig. 1D) analyzed 16 days following completion of
co-culture. Timepoints indicate the delay between vector exposure of
1o cells and initiation of co-culture (0-, 24-, 48-, 72 hr)
Found at: doi:10.1371/journal.pone.0006219.s001 (0.56 MB TIF)
Figure S2 (A) Effect of inhibition of canonical viral trafficking
pathways on 2o transfer. Jurkat carrier cells were pretreated with
escalating doses of each inhibitor, followed by vector exposure,
pronase wash, and 24-hour coculture with 293T cells. GFP
marking in 2o cells is shown. Trafficking pathways targeted are:
proteosome (MG 132), lysosome (Bafilomycin A), actin-cytoskel-
eton (Latrunculin B). To confirm that doses of Latrunculin B used
had biologic effect on the cells, the experiments were repeated with
Latrunculin A, with similar results observed (not shown).
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PLoS ONE | www.plosone.org 10 July 2009 | Volume 4 | Issue 7 | e6219Therefore, GFP-vpr vector-exposed cells were treated with 1 mM
Latrunculin A, cells were stained with anti-CD63 (far-red). (B)
Genomes (green) associated with CD63 were enumerated in cells
without (top panels) or following (bottom panels) Latrunculin A
treatment. (C) The difference in genomes associated with CD63
following Latrunculin A treatment was statistically different from
non-treated control, confirming that the doses of inhibitor used
exerted a biologic effect on the cells. (D) Representative images of
vector genomes colocalized with endosomal markers in Jurkat cells
following a 1-hr or 24-hr exposure (from Fig. 3C,D).
Found at: doi:10.1371/journal.pone.0006219.s002 (2.86 MB TIF)
Table S1 Number of cells counted in the experiments used to
generate figure panels.
Found at: doi:10.1371/journal.pone.0006219.s003 (0.07 MB
RTF)
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